Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP – Get Free Report) was the recipient of a large growth in short interest in the month of January. Optivise Advisory Services LLC grew its holdings in shares of Aspire Biopharma by 120.9% during the second quarter. Get Aspire Biopharma alerts:Aspire Biopharma Price PerformanceNASDAQ:ASBP opened at $1.59 on Thursday. Aspire Biopharma has a 1-year low of $1.42 and a 1-year high of $632.00. Recommended StoriesReceive News & Ratings for Aspire Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspire Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.